​​​​InMode Australia is proud to partner with leading South Korean biopharmaceutical company ExoCoBio, as the exclusive distributor of the Advanced Skincare Complex from ExoCoBio.

ASCE+ Exosomes are a cutting-edge biotech skin and hair rejuvenation and intimate care treatment that harnesses the power of growth factors, peptides, co-enzymes, minerals, amino acids, and vitamins, to enhance collagen production, reduce inflammation and improve skin texture and tone.

InMode Australia Managing Director, Dennis Cronje, said the introduction of ASCE+ Exosomes will greatly complement and enhance treatments such as the flagship Morpheus8, by significantly reducing inflammation and healing time, and further improving the skins condition.

“We are pleased to be partnering with ExoCoBio to bring the industry’s most advanced exosome solutions to the Australian healthcare and aesthetic market,” Mr Cronje said.

“The combination of exosomes with Morpheus8 RF microneedling treatments, as well as any disruptive facial or scalp treatment, including laser, IPL, needling, or chemical peels, can deliver significant benefits by promoting collagen remodelling and reducing the downtime and discomfort associated with skin trauma,” he added.

“ExoCoBio has garnered international recognition for its exosome products. They are known as the leaders in their field, having conducted extensive clinical research, have the most published studies, and the most peer reviewed papers. So, we know they’re the best.”

Exosomes are a type of extracellular vesicle (tiny fluid sack) that communicates and transmits signals between cells to promote collagen production and skin regeneration, for a more youthful appearance.

Registered clinicians and practitioners can access ASCE+ Exosomes via inmode.com.au or directly here.

​​​​MORE ON ASCE+ EXOSOMES

About InMode 

InMode is a leading global provider of innovative medical technologies.  InMode develops, manufactures, and markets devices harnessing novel radiofrequency (“RF”) technology. InMode strives to enable new emerging procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for aesthetic medicine, plastic surgery, gynaecology, dermatology, optometry, and ophthalmology.

Previous articleXytide Biotech introduces e.p.t.q.
Next articleMelbourne compounding pharmacy raided in ongoing investigation of copycat ‘Ozempic’ manufacturing